SATIXFY COMMUNICATIONS LTD SEC Filings

Prologis, Inc. (PLD) – Form 4 insider filing

Director Olivier Piani reported a routine, non-cash equity accrual on 30 June 2025. He received 60.9619 Dividend Equivalent Units (DEUs) credited at a cost basis of $0 under the company’s Non-Qualified Deferred Compensation Plan. DEUs are tied to outstanding Deferred Stock Units (DSUs) and accrue whenever Prologis pays a common-stock dividend. Following the credit, Piani now beneficially owns 6,405.8173 DSUs/DEUs, all held directly. No common shares were bought or sold and there was no market transaction impact. The filing was signed 2 July 2025.

This event modestly increases insider alignment but is immaterial to share count and valuation.

SatixFy Communications Ltd. (SATX) has filed Post-Effective Amendment No. 1 to its 2022 Form F-4 in order to deregister all securities originally covered by that registration statement. The prior Form F-4 had registered up to 24.2 million ordinary shares, 17.63 million warrants and an equal number of warrant-exercise shares.

The amendment follows the closing of a previously announced transaction under the Agreement and Plan of Merger dated April 1 2025. On July 2 2025, two wholly-owned subsidiaries of MDA Space Ltd. (Merger Sub 1 and Merger Sub 2) were merged into SatixFy. As a result, SatixFy became an indirect wholly-owned subsidiary of MDA Space and has terminated all public offerings under the Form F-4. The company is therefore removing all registered securities and terminating the effectiveness of the registration statement.

• This is an administrative step required after completion of the MDA Space–SatixFy merger.
• No additional securities will be offered or sold pursuant to the original registration statement.
• The filing is signed by CEO Nir Barkan and SatixFy’s U.S. representative, Cogency Global Inc.

SatixFy Communications Ltd. (SATX) has filed Post-Effective Amendments to two previously effective Form F-1 registration statements to terminate all registered offerings and deregister any unsold securities. The action follows the closing of a two-step merger completed on 2 July 2025 under an Agreement and Plan of Merger dated 1 April 2025 with MDA Space Ltd. and two Israeli merger subsidiaries. After the transactions, SatixFy became an indirect, wholly owned subsidiary of MDA Space Ltd. and ceased to be an independent public issuer.

The amendments cover:

• Registration No. 333-268510 – originally effective 23 Jan 2023, permitting resale of up to 28,373,475 ordinary shares and 1,000,000 warrants.
• Registration No. 333-268835 – originally effective 24 May 2023, allowing CF Principal Investments LLC to sell ordinary shares up to an aggregate $77.25 million under an equity line of credit.

With the merger completed, SatixFy states that all offerings under these F-1s are terminated and all unsold securities are removed from registration. Upon SEC effectiveness of the amendments, the two registration statements will no longer be available for use. The filing is signed by CEO Nir Barkan in Israel and by Cogency Global Inc. as authorised U.S. representative.

Key investor takeaway: The company will no longer issue or resell securities under the referenced F-1 shelves, confirming its transition into a private, wholly owned subsidiary of MDA Space Ltd.

SatixFy Communications Ltd. ("SATX") filed Post-Effective Amendment No. 1 and No. 2 to its prior Form F-1 registration statements (333-268510 and 333-268835).

• Purpose: Terminate all outstanding securities offerings and deregister any unsold ordinary shares and warrants that had been registered for resale or for an equity line of credit worth up to US$77.25 million.
• Triggering event: On 2 July 2025, SatixFy completed a two-step merger with MDA Space Ltd. (Ontario) via Merger Sub 1 and Merger Sub 2. Following the transactions, SatixFy survives as an indirect wholly-owned subsidiary of MDA Space.
• Because SatixFy is now privately held within MDA Space, public offerings under the two Form F-1 shelves are no longer required and have been withdrawn.
• The filing formally ends the effectiveness of both registration statements once the SEC declares these amendments effective.
• Signatories: CEO Nir Barkan (Rehovot, Israel) and authorised U.S. representative Colleen A. De Vries of Cogency Global Inc. (New York).

No new financial statements or earnings data accompany this filing; it is an administrative step confirming that previously registered securities will not be sold in the public market.

Citigroup Global Markets Holdings Inc. (guaranteed by Citigroup Inc.) is offering unsecured, senior medium-term notes in the form of Buffer Securities linked to the S&P 500 Futures Excess Return Index (ticker SPXFP). The securities price on 30 Jun 2025, settle on 3 Jul 2025 and mature on 5 Jul 2030.

Key economic terms

• Stated principal: $1,000 per note; total offering $436,000.
• Upside participation: 170 % of any index appreciation.
• Downside protection: 20 % buffer; losses accrue 1-for-1 below 80 % of initial value (514.49).
• No interest payments; no dividend entitlement.
• Estimated value at pricing: $960, 4 % below issue price, reflecting selling, hedging and funding costs.
• Underwriting fee: up to $11.25 (1.125 %) per security; proceeds to issuer $988.75.
• Listing: none; secondary market, if any, provided only by CGMI.

Risk highlights

• Credit risk of both Citigroup Global Markets Holdings Inc. and Citigroup Inc.
• The underlying futures-based index historically underperforms the price and total-return S&P 500 due to embedded financing costs (1-, 3- and 5-year annualised returns of 8.73 %, 13.58 % and 12.78 % versus 13.55 %, 17.89 % and 14.88 % for the S&P 500).
• Liquidity: notes are not exchange-listed; CGMI may discontinue market-making at any time.
• Investors forgo coupons, dividends and interim averaging; payoff depends solely on the final valuation date.
• Estimated value and any secondary bid will be reduced by internal funding rate, bid-ask spreads and hedging unwind costs.
• Complex U.S. federal tax treatment (prepaid forward contract) remains uncertain.

Investor profile: Suitable only for sophisticated investors seeking leveraged upside to a futures-based equity index, willing to accept structural complexity, credit exposure, potential capital loss beyond the 20 % buffer and limited liquidity for five years.

Maravai LifeSciences Holdings, Inc. (MRVI) – Form 4 filing dated 06/18/2025

The filing discloses that director Constantine S. Mihas was granted 89,139 Class A common stock restricted stock units (RSUs) on 06/16/2025 under the company’s 2020 Omnibus Incentive Plan. The award is reported under Transaction Code “A” (acquisition). The RSUs vest in full on the earlier of (i) one year from grant or (ii) the 2026 annual meeting of stockholders. A reference price of $2.16 per share is listed in the price column.

Following this transaction, the reporting person shows 138,055 shares owned directly. However, the footnotes clarify that these shares are held for the benefit of a GTCR-affiliated entity; Mr. Mihas disclaims any pecuniary interest.

• No derivative securities were reported.
• The filing was signed by Kurt Oreshack under power of attorney on 06/18/2025.

The Form 4 reflects routine board compensation and does not indicate open-market purchases or sales. The share amount is modest relative to MRVI’s public float and therefore unlikely to be material to overall share supply or insider sentiment.

Alarum Technologies Ltd. (NASDAQ: ALAR) has filed a Form 6-K to furnish notice and proxy materials for its Annual and Extraordinary General Meeting of Shareholders, scheduled for 7 August 2025 at 3:00 p.m. Israel time. Only holders of ordinary shares or American Depositary Shares (ADSs) of record at the close of business on 9 July 2025 may vote.

The filing attaches four exhibits: (1) meeting notice, (2) proxy statement, (3) proxy card, and (4) ADS voting instruction form. No financial statements, earnings data, or transaction details are included. The Form 6-K is automatically incorporated by reference into several outstanding S-8 and F-3 registration statements, a routine step to keep those documents current.

From an investment perspective, the submission is procedural rather than financial; it simply initiates the annual corporate governance cycle and enables shareholders to vote on proposals that will be described in the proxy statement (not supplied here). The filing does not signal any immediate change in Alarum’s operations, strategy, or financial outlook.